Jump to content


Congrats to Margaret, Platinum Member with 1,000 posts and 10 Years of Forums Membership!


Photo

Long-Term Safety And Efficacy Of Therapeutic Angiogenesis By The Autologous Transplantation Of Bone-Marrow Derived Cells Against Intractable Skin Ulcer In Patients With System


  • Please log in to reply
No replies to this topic

#1 Joelf

Joelf

    Star Ruby Member

  • ISN Root Admin
  • PipPipPipPipPipPipPipPipPipPipPipPipPip
  • 4,610 posts
  • Location:West Sussex

Posted 10 October 2011 - 06:14 AM

Long-Term Safety And Efficacy Of Therapeutic Angiogenesis By The Autologous Transplantation Of Bone-Marrow Derived Cells Against Intractable Skin Ulcer In Patients With Systemic Sclerosis (Ssc).

Therapeutic angiogenesis by the autologous transplantation in SSc patients was found to be an effective and safe approach to intractable ulcers in long-term observational study. A. Ihata. EULAR 2011 OPO304. Ann rheumatologist Dis 2011;70(Suppl3):176. (Also see: Digital Ulcers)

This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.

Jo Frowde
ISN Assistant Webmaster

SD World Webmaster
ISN Sclero Forums Manager
ISN News Manager

ISN Hotline Support Specialist
ISN Chat Host
International Scleroderma Network (ISN)